Chemical genetic approaches to probing cell death

Current Opinion in Chemical Biology

Volumn 11, Issue 1, 2007, Pages 83-87

  Gangadhar, Nidhi M ^a   Stockwell, Brent R ^a  

^a Department of Biological Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APROTOXIN A; CYTOTOXIC AGENT; ERASTIN; HISTONE DEACETYLASE INHIBITOR; NECROSTATIN 1; TRAPOXIN A; TRAPOXIN B; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT;

CELL DEATH; CHEMICAL GENETICS; DISEASE COURSE; DRUG MECHANISM; GENE OVEREXPRESSION; GENE PROBE; GENE TARGETING; HUMAN; MAMMAL CELL; MORTALITY; ONCOGENE H RAS; PHENOTYPE; PROTEIN TARGETING; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DEPSIPEPTIDES; GENETIC TECHNIQUES; GENOME; HUMANS; IMIDAZOLES; INDOLES; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; PHENOTYPE; PIPERAZINES; PROTEINS;

MAMMALIA;

EID: 33846867974     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.11.033     Document Type: Review

References (43)

1. Schafer Z.T., and Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10 (2006) 549-561
2. Malaguarnera L. Implications of apoptosis regulators in tumorigenesis. Cancer Metastasis Rev 23 (2004) 367-387
3. Ekshyyan O., and Aw T.Y. Apoptosis: a key in neurodegenerative disorders. Curr Neurovasc Res 1 (2004) 355-371
4. Metzstein M.M., Stanfield G.M., and Horvitz H.R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 14 (1998) 410-416
5. Sulston J.E., and Horvitz H.R. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56 (1977) 110-156
6. Ward S., Thomson N., White J.G., and Brenner S. Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans. J Comp Neurol 160 (1975) 313-337
7. Hay B.A., Huh J.R., and Guo M. The genetics of cell death: approaches, insights and opportunities in Drosophila. Nat Rev Genet 5 (2004) 911-922. This review describes similarities in the cell death machinery of flies, worms and mammals. The authors discuss advantages of using Drosophila to study cell death pathways, including ease of targeting specific genes, number of available fly lines containing single-gene mutations, the ability to drive tissue-specific gene expression, spatial and temporal control over RNAi-mediated knockdown, and genetic screening strategies to identify genes of interest.
8. Huang Z. The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules. Chem Biol 9 (2002) 1059-1072
9. Stockwell B.R. Exploring biology with small organic molecules. Nature 432 (2004) 846-854. This review discusses the potential to explore biological activity with small organic molecules. Parallels between molecular genetics and chemical genetics are drawn; challenges to chemical genetics are presented and addressed. Finally, the author discusses strategies for screening in high-throughput and target identification.
10. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298. This group has developed lentiviral short hairpin RNA (shRNA) libraries targeting the human and murine genomes. To demonstrate the power and applicability of this resource, they use the library to screen for genes regulating mitotic progression in human cancer cells.
11. Pritsker M., Ford N.R., Jenq H.T., and Lemischka I.R. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci USA 103 (2006) 6946-6951. These researchers performed a genetic overexpression screen using a genome-wide cDNA library. With the use of microarray detection methods and high-throughput functional analyses, they identified genes that regulate differentiation in mouse embryonic stem (ES) cells. The methods they discuss can be applied to screening for various phenotypes in ES cells and other cell lines of interest.
12. Beissbarth T., and Speed T.P. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20 (2004) 1464-1465. This paper describes software that has been developed to analyze data accumulated from microarray experiments, or other experiments that produce long lists of genes. The program, GOstat, takes information from the Gene Ontology (GO) database, which contains functional annotations of all genes, to identify which annotations are statistically overrepresented within a given list of genes.
13. Root D.E., Hacohen N., Hahn W.C., Lander E.S., and Sabatini D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 3 (2006) 715-719
14. Mondal K., and Gupta M.N. The affinity concept in bioseparation: evolving paradigms and expanding range of applications. Biomol Eng 23 (2006) 59-76
15. Wajant H. The Fas signaling pathway: more than a paradigm. Science 296 (2002) 1635-1636
16. Mattson M.P., and Kroemer G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9 (2003) 196-205
17. Yuan J., Lipinski M., and Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40 (2003) 401-413
18. Boyce M., Degterev A., and Yuan J. Caspases: an ancient cellular sword of Damocles. Cell Death Differ 11 (2004) 29-37
19. Nicotera P., and Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 23 (2004) 2757-2765. This review examines the factors that determine which type of cell death will progress in various physiological conditions, and how various death pathways intertwine. The authors suggest that ATP levels and nitric oxide are both key regulators in determining the mechanism and morphology of death.
20. Marks P.A., Richon V.M., Breslow R., and Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13 (2001) 477-483
21. Itazaki H., Nagashima K., Sugita K., Yoshida H., Kawamura Y., Yasuda Y., Matsumoto K., Ishii K., Uotani N., Nakai H., et al. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. J Antibiot (Tokyo) 43 (1990) 1524-1532
22. Furumai R., Komatsu Y., Nishino N., Khochbin S., Yoshida M., and Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci USA 98 (2001) 87-92
23. Spiller S.E., Ravanpay A.C., Hahn A.W., and Olson J.M. Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. J Neurooncol 79 (2006) 259-270
24. Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VN et al.: Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 2006, in press.
25. Wirth B., Brichta L., Schrank B., Lochmuller H., Blick S., Baasner A., and Heller R. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119 (2006) 422-428
26. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., Cuny G.D., Mitchison T.J., Moskowitz M.A., and Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1 (2005) 112-119. This paper describes a novel pathway leading to cell death, in which an apoptotic stimuli leads to death that displays characteristics of necrosis (termed 'necroptosis'). The authors perform a screen to find a small molecule inhibitor of this pathway, and use this inhibitor to demonstrate the physiological relevance of this type of death in an induced stroke model in mice.
27. Lou M., Chen Y., Ding M., Eschenfelder C.C., and Deuschl G. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res Bull 69 (2006) 109-116
28. Teng X., Degterev A., Jagtap P., Xing X., Choi S., Denu R., Yuan J., and Cuny G.D. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 15 (2005) 5039-5044. A structure-activity relationship of 71 analogs of novel necroptosis inhibitor, necrostatin-1 (Nec-1) shows that most positions are highly sensitive to substitutions; however, variations at the indole 7 position increased necroptosis inhibitory activity.
29. Luesch H., Chanda S.K., Raya R.M., DeJesus P.D., Orth A.P., Walker J.R., Izpisua Belmonte J.C., and Schultz P.G. A functional genomics approach to the mode of action of apratoxin A. Nat Chem Biol 2 (2006) 158-167. This study describes the mode of action of cytotoxic agent aprotoxin A (AprA), as revealed by a genome-wide overexpression screen for resistance. Overexpression of several FGFRs confers resistance to AprA toxicity; AprA inhibits the phosphorylation of the FGFR target STAT3, resulting in AprA-induced death.
30. Williams P.G., Yoshida W.Y., Moore R.E., and Paul V.J. Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp. J Nat Prod 65 (2002) 1336-1339
31. Williams P.G., Yoshida W.Y., Moore R.E., and Paul V.J. Tasipeptins A and B, new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. J Nat Prod 66 (2003) 620-624
32. Williams P.G., Yoshida W.Y., Moore R.E., and Paul V.J. Micromide and guamamide: cytotoxic alkaloids from a species of the marine cyanobacterium Symploca. J Nat Prod 67 (2004) 49-53
33. Williams P.G., Yoshida W.Y., Quon M.K., Moore R.E., and Paul V.J. Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp. J Nat Prod 66 (2003) 651-654
34. Luesch H., Yoshida W.Y., Moore R.E., Paul V.J., and Corbett T.H. Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J Am Chem Soc 123 (2001) 5418-5423
35. Xie T.X., Huang F.J., Aldape K.D., Kang S.H., Liu M., Gershenwald J.E., Xie K., Sawaya R., and Huang S. Activation of Stat3 in human melanoma promotes brain metastasis. Cancer Res 66 (2006) 3188-3196. Increases in STAT3 activity were discovered in human brain metastatic melanoma cells. Furthermore, transfection with constitutively active or dominant negative STAT3, respectively, enhances or suppresses brain metastasis, and alterations in STAT3 activity affect angiogenesis.
36. Xie T.X., Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., and Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23 (2004) 3550-3560
37. Kawakami Y., Esteban C.R., Matsui T., Rodriguez-Leon J., Kato S., and Belmonte J.C. Sp8 and Sp9, two closely related buttonhead-like transcription factors, regulate Fgf8 expression and limb outgrowth in vertebrate embryos. Development 131 (2004) 4763-4774
38. Dolma S., Lessnick S.L., Hahn W.C., and Stockwell B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3 (2003) 285-296
39. Buck L., and Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65 (1991) 175-187
40. Carleton A., Petreanu L.T., Lansford R., Alvarez-Buylla A., and Lledo P.M. Becoming a new neuron in the adult olfactory bulb. Nat Neurosci 6 (2003) 507-518
41. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat Med 4 (1998) 1313-1317
42. Calof A.L., Rim P.C., Askins K.J., Mumm J.S., Gordon M.K., Iannuzzelli P., and Shou J. Factors regulating neurogenesis and programmed cell death in mouse olfactory epithelium. Ann N Y Acad Sci 855 (1998) 226-229
43. Kawauchi S., Beites C.L., Crocker C.E., Wu H.H., Bonnin A., Murray R., and Calof A.L. Molecular signals regulating proliferation of stem and progenitor cells in mouse olfactory epithelium. Dev Neurosci 26 (2004) 166-180